Annals of internal medicine, residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis, A randomized trial

Annals of Internal Medicine

Volumn 150, Issue 9, 2009, Pages 577-585

  Prandoni, Paolo ^a   Prins, Martin H ^b   Lensing, Anthonie W A ^c   Ghirarduzzi, Angelo ^d   Ageno, Walter ^e   Imberti, Davide ^f   Scannapieco, Gianluigi ^g   Ambrosio, Giovanni B ^h   Pesavento, Raffaele ⁱ   Cuppini, Stefano ^j   Quintavalla, Roberto ^k   Agnelli, Giancarlo ^l  

^a UNIVERSITY OF PADOVA   (Italy)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d S MARIA NUOVA HOSPITAL   (Italy)

^e UNIVERSITY OF INSUBRIA   (Italy)

^f Ospedale Civile   (Italy)

^g Treviso Healthcare Authority   (Italy)

^h Hospital of Venice   (Italy)

ⁱ Civic Hospital   (Italy)

^j Civic Hospital   (Italy)

^k UNIVERSITY HOSPITAL OF PARMA   (Italy)

^l UNIVERSITY OF PERUGIA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG FATALITY; ECHOGRAPHY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SINGLE BLIND PROCEDURE; TREATMENT DURATION; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; URINARY TRACT HEMORRHAGE; VENOUS THROMBOEMBOLISM; BLEEDING; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; MIDDLE AGED; PROGNOSIS; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; VENOUS THROMBOSIS;

EID: 65649094470     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-150-9-200905050-00003     Document Type: Article

References (27)

1. Segal JB, Streiff MB, Hofmann LV, Hoffman LV, Thornton K, Bass EB.Management of venous thromboembolism: a systematic review for a practice guideline. Ann Intern Med. 2007;146:211-22. [PMID: 17261856]
2. Ost D, Tepper J, Mihara H, Lander O, Heinzer R, Fein A. Duration of anticoagulation following venous thromboembolism: a meta-analysis. JAMA. 2005;294:706-15. [PMID: 16091573]
3. Streiff MB, Segal JB, Tamariz LJ, Jenckes MW, Bolger DT, Eng J, et al. Duration of vitamin K antagonist therapy for venous thromboembolism: a systematic review of the literature. Am J Hematol. 2006;81:684-91. [PMID: 16838335]
4. Schulman S, Granqvist S, Holmstrom M, Carlsson A, Lindmarker P, Nicol P, et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N Engl J Med. 1997;336:393-8. [PMID: 9010144]
5. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ; American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:454S-545S. [PMID: 18574272]
6. Cardiovascular Disease Educational and Research Trust. Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol. 2006;25:101-61. [PMID: 16763532]
7. Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, et al. The risk of recurrent venous thromboembolism after discontinuing antico- agulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica. 2007; 92:199-205. [PMID: 17296569]
8. Prandoni P, Lensing AW, Prins MH, Bernardi E, Marchiori A, Bagatella P, et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med. 2002;137:955-60. [PMID: 12484710]
9. Piovella F, Crippa L, Barone M, Vigano D'Angelo S, Serafini S, Galli L, et al. Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis. Haematologica. 2002;87:515-22. [PMID: 12010666]
10. Young L, Ockelford P, Milne D, Rolfe-Vyson V, Mckelvie S, Harper P. Post-treatment residual thrombus increases the risk ofrecurrent deep vein thrombosis and mortality. J Thromb Haemost. 2006;4:1919-24. [PMID: 16836658]
11. Simioni P. The molecular genetics of familial venous thrombosis. Baillieres Best Pract Res Clin Haematol. 1999;12:479-503. [PMID: 10856982]
12. Prandoni P, Cogo A, Bernardi E, Villalta S, Polistena P, Simioni P, et al. A simple ultrasound approach for detection of recurrent proximal-vein thrombosis. Circulation. 1993;88:1730-5. [PMID: 8403319]
13. Pinede L, Ninet J, Duhaut P, Chabaud S, Demolombe-Rague S, Durieu I, et al; Investigators of the "Duree Optimale du Traitement AntiVitamines K" (DOTAVK) Study. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of6 and 12 weeks oftherapy after isolated calfdeep vein thrombosis. Circulation. 2001;103:2453-60. [PMID: 11369685]
14. Siragusa S, Malato A, Anastasio R, Cigna V, Milio G, Amato C, et al. Residual vein thrombosis to establish duration of anticoagulation after a first episode ofdeep vein thrombosis: the Duration ofAnticoagulation based on Compression UltraSonography (DACUS) study. Blood. 2008;112:511-5. [PMID: 18497320]
15. Prandoni P, Lensing AW, Bernardi E, Villalta S, Bagatella P, Girolami A, et al; DERECUS Investigators Group. The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost. 2002;88:402-6. [PMID: 12353067]
16. Prandoni P, Tormene D, Dalla Valle F, Concolato A, Pesavento R. D-dimer as an adjunct to compression ultrasonography in patients with suspected recurrent deep vein thrombosis [Letter]. J Thromb Haemost. 2007;5:1076-7. [PMID: 17367489]
17. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Larfars G, Nicol P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med. 1995;332:1661-5. [PMID: 7760866]
18. Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, et al; Warfarin Optimal Duration Italian Trial Investigators. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med. 2001;345:165-9. [PMID: 11463010]
19. Agnelli G, Prandoni P, Becattini C, Silingardi M, Taliani MR, Miccio M, et al; Warfarin Optimal Duration Italian Trial Investigators. Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med. 2003;139:19-25. [PMID: 12834314]
20. Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al; PREVENT Investigators. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med. 2003; 348:1425-34. [PMID: 12601075]
21. Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, et al; Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembo- lism. N Engl J Med. 2003;349:631-9. [PMID: 12917299]
22. Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, et al; PROLONG Investigators. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med. 2006;355:1780-9. [PMID: 17065639]
23. Stain M, Schonauer V, Minar E, Bialonczyk C, Hirschl M, Weltermann A, et al. The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemost. 2005;3:2671-6. [PMID: 16359506]
24. Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ. 2008;179:417-26. [PMID: 18725614]
25. Palareti G, Legnani C, Cosmi B, Guazzaloca G, Cini M, Mattarozzi S. Poor anticoagulation quality in the first 3 months after unprovoked venous thrombo- embolism is a risk factor for long-term recurrence. J Thromb Haemost. 2005;3: 955-61. [PMID: 15869591]
26. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA. 1998;279:458-62. [PMID: 9466640]
27. Douketis JD, Gu CS, Schulman S, Ghirarduzzi A, Pengo V, Prandoni P. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med. 2007;147:766-74. [PMID: 18056660]